Paper35732829
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Alaggio R and 82 others. Leukemia, 2022. Cited by 3,367 papers, by iCite.
Cite this record
ConductScience Library. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Papers, record 35732829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35732829
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hematologic Neoplasms | Major topic |
| Lymphoma | Major topic |
| Humans | |
| World Health Organization |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K08 CA267058 | NCI NIH HHS | United States | K08CA267058 | PubMed and NIH | NIH RePORTER |
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH | NIH RePORTER |
Trials4
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT06256484 | A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma | Results | ClinicalTrials.gov | |
| NCT07499635 | Immunophenotypic Evaluation of CD305 and CD85d in B-Cell Lymphoid Neoplasms | Background | ClinicalTrials.gov | |
| NCT07652580 | Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma | Background | ClinicalTrials.gov | |
| NCT07678229 | BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL | Results | ClinicalTrials.gov |
Comments and corrections3
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Erratum in | 37468552 | Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748. | https://conductscience.org/library/papers/37468552 | PubMed |
| Comment in | 36708220 | ALK1-negative primary cutaneous anaplastic large cell lymphoma of the hand and wrist. | https://conductscience.org/library/papers/36708220 | PubMed |
| Comment in | 36973349 | Response to the Comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors. | https://conductscience.org/library/papers/36973349 | PubMed |
References293
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8068936 | A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. | Blood | 1994 | https://conductscience.org/library/papers/8068936 | PubMed |
| 2 | 28087540 | International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. | Blood | 2017 | https://conductscience.org/library/papers/28087540 | PubMed |
| 3 | 31352991 | Castleman Disease. | Surg Pathol Clin | 2019 | https://conductscience.org/library/papers/31352991 | PubMed |
| 4 | 21487108 | High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy. | Blood | 2011 | https://conductscience.org/library/papers/21487108 | PubMed |
| 5 | 17664482 | Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17664482 | PubMed |
| 6 | 34529020 | ALL is not the same in the era of genetics. | Blood | 2021 | https://conductscience.org/library/papers/34529020 | PubMed |
| 7 | 23181981 | A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13). | Cancer Genet | 2012 | https://conductscience.org/library/papers/23181981 | PubMed |
| 8 | 26214592 | Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options. | Nat Genet | 2015 | https://conductscience.org/library/papers/26214592 | PubMed |
| 9 | 28408464 | Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group. | Blood | 2017 | https://conductscience.org/library/papers/28408464 | PubMed |
| 10 | 27870571 | High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/27870571 | PubMed |
| 11 | 28749919 | Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtype. | Clin Adv Hematol Oncol | 2017 | https://conductscience.org/library/papers/28749919 | PubMed |
| 12 | 33054045 | BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy. | Haematologica | 2020 | https://conductscience.org/library/papers/33054045 | PubMed |
| 13 | 31434701 | Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements. | Blood | 2019 | https://conductscience.org/library/papers/31434701 | PubMed |
| 14 | 27265895 | Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. | Nat Commun | 2016 | https://conductscience.org/library/papers/27265895 | PubMed |
| 15 | 27019113 | Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. | Nat Genet | 2016 | https://conductscience.org/library/papers/27019113 | PubMed |
| 16 | 27824051 | Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia. | Nat Commun | 2016 | https://conductscience.org/library/papers/27824051 | PubMed |
| 17 | 27634205 | ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype. | Haematologica | 2017 | https://conductscience.org/library/papers/27634205 | PubMed |
| 18 | 30872366 | NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2. | Haematologica | 2019 | https://conductscience.org/library/papers/30872366 | PubMed |
| 19 | 30282799 | IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas. | Blood | 2018 | https://conductscience.org/library/papers/30282799 | PubMed |
| 20 | 30643249 | PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. | Nat Genet | 2019 | https://conductscience.org/library/papers/30643249 | PubMed |
Cited by2,348
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,367 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985352 | Hematologic Malignancies Survival Patterns in Elderly Patients: Disparities in Martinique, a Caribbean Population-Based Registry Study, 2008-2021. | Clin Epidemiol | 2026 | https://conductscience.org/library/papers/42985352 | PubMed |
| 42979429 | Hematologic breast malignancies: a single-institution cohort study of 24 patients diagnosed between January 2008 and June 2023, with clinicopathological and outcome analysis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42979429 | PubMed |
| 42974429 | Secondary intraocular extranodal natural killer/T-cell lymphoma with optic nerve involvement: a case report. | Front Oncol | 2026 | https://conductscience.org/library/papers/42974429 | PubMed |
| 42967967 | Posttransplant lymphoproliferative disorders following hematopoietic stem cell transplantation: a clinicopathological study of a large single-center cohort. | Ann Hematol | 2026 | https://conductscience.org/library/papers/42967967 | PubMed |
| 42967949 | A multi-center, single-arm, phase 2 trial of dasatinib in T follicular helper cell lymphomas. | Nat Commun | 2026 | https://conductscience.org/library/papers/42967949 | PubMed |
| 42967050 | Jejunal B-Cell Non-Hodgkin Lymphoma Presenting with a Long Stenosing Lesion in an Adolescent: A Case Report. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42967050 | PubMed |
| 42960382 | Colonic Mucosa-Associated Lymphoid Tissue Following Prior Hodgkin Lymphoma: A Diagnostic Challenge and Therapeutic Approach - A Case Report. | GE Port J Gastroenterol | 2026 | https://conductscience.org/library/papers/42960382 | PubMed |
| 42959668 | Aberrant Cluster of Differentiation (CD) Marker Expression Across B-cell Chronic Lymphoproliferative Disorder Subtypes: A Single-Center Flow Cytometry Study From Sri Lanka. | Cureus | 2026 | https://conductscience.org/library/papers/42959668 | PubMed |
| 42959663 | Immune Background Profiles Across B-cell Lymphoproliferative Disorders. | Cureus | 2026 | https://conductscience.org/library/papers/42959663 | PubMed |
| 42959460 | Calcineurin Inhibitor-Free, mTOR-Based Immunosuppression in Chimeric Antigen Receptor T-Cell Therapy for Post-Transplant Lymphoproliferative Disorder. | EJHaem | 2026 | https://conductscience.org/library/papers/42959460 | PubMed |
| 42959303 | Nodal T Follicular Helper Cell Lymphoma With Epstein-Barr Virus-Positive Neoplastic T Cells Derived From Clonal Hematopoiesis. | EJHaem | 2026 | https://conductscience.org/library/papers/42959303 | PubMed |
| 42948798 | Vitality as a Prognostic Biomarker in Hematologic Malignancies: Association With Overall Survival and Progression-Free Survival. | Cureus | 2026 | https://conductscience.org/library/papers/42948798 | PubMed |
| 42947919 | Sintilimab plus R-CHOP versus DA-EPOCH-R as first-line therapy for primary mediastinal large B-cell lymphoma: a real-world comparative cohort study. | Front Immunol | 2026 | https://conductscience.org/library/papers/42947919 | PubMed |
| 42943337 | Obinutuzumab and Chemotherapy for Front-Line Treatment of Follicular Lymphoma Grade 3B and Composite Follicular Lymphoma: A Study of the Croatian Cooperative Group for Hematologic Diseases (KroHem). | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943337 | PubMed |
| 42942121 | Copy-Number Alterations and Copy-Neutral Loss of Heterozygosity in Adult T-ALL: A Descriptive Study in Relation to Day +70 MRD. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42942121 | PubMed |
| 42940088 | Richter Transformation of Chronic Lymphocytic Leukaemia: Biology, Diagnosis, and an Evolving Therapeutic Landscape. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940088 | PubMed |
| 42939957 | Plasma IgG N-Glycosylation as a Novel Biomarker of Disease Severity and Prognosis in Diffuse Large B-Cell Lymphoma, Not Otherwise Specified. | Biomedicines | 2026 | https://conductscience.org/library/papers/42939957 | PubMed |
| 42938940 | Conserved Regulatory DNA Methylation in Human and MYC/PI3K-Driven Murine EBV-Negative Burkitt Lymphoma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42938940 | PubMed |
| 42938932 | Targeting Peripheral T-Cell Lymphomas with Chimeric Antigen Receptor Therapy: Mechanistic Challenges, Clinical Landscape and Future Engineering Perspectives. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42938932 | PubMed |
| 42938799 | Vitreoretinal Lymphoma: From Pathobiology to Integrated Diagnosis. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42938799 | PubMed |
Genes113
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35732829
GET https://conductscience.org/api/papers/v1/35732829/authors?page=2